Track Acutaas Chemicals Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: 0.25 %
Low
3,120.0
High
3,237.9
1 Month returns: -3.48 %
Low
3,081.2
High
3,399.9
1 Year returns: 116.63 %
Low
1,290.1
High
3,740.0
3 Year CAGR: 68.46 %
Low
502.2
High
3,740.0
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Acutaas Chemicals Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Acutaas Chemicals Ltd. Shareholding Pattern
Quarterly breakdown of Acutaas Chemicals Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Acutaas Chemicals Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Acutaas Chemicals Ltd.?
The current share price of Acutaas Chemicals Ltd. is ₹ 3,182.10 as of 8 Sep 2026.
What is the market capitalisation of Acutaas Chemicals Ltd.?
The market capitalisation of Acutaas Chemicals Ltd. stands at ₹ 26,052.20 Cr.
What is the PE ratio of Acutaas Chemicals Ltd.?
The Price-to-Earnings (PE) ratio of Acutaas Chemicals Ltd. is 67.33 as of the latest trailing twelve months data.
What is the ROE and ROCE of Acutaas Chemicals Ltd.?
Acutaas Chemicals Ltd. has a Return on Equity (ROE) of 24.05% and a Return on Capital Employed (ROCE) of 28.86% as per the latest financial reports.
What is the 52-week high and low of Acutaas Chemicals Ltd.?
The 52-week high of Acutaas Chemicals Ltd. is - and the 52-week low is -.
What is the dividend yield of Acutaas Chemicals Ltd.?
The dividend yield of Acutaas Chemicals Ltd. is 0.08% based on the current market price.
What is the FII and DII holding in Acutaas Chemicals Ltd.?
Foreign Institutional Investors (FII) hold 21.61%, Domestic Institutional Investors (DII) hold 17.78% and retail/public investors hold 24.91% of Acutaas Chemicals Ltd. shares.
What sector does Acutaas Chemicals Ltd. belong to?
Acutaas Chemicals Ltd. operates in the Healthcare sector. 75% of analysts have a Buy or Strong Buy rating on Acutaas Chemicals Ltd. with a consensus target price of ₹ 3,257.00, implying 2.35% upside from current levels.
What is the beta of Acutaas Chemicals Ltd.?
The beta of Acutaas Chemicals Ltd. is 0.87, indicating its price volatility relative to the broader market. Over the past 1 year, Acutaas Chemicals Ltd. has delivered an absolute return of 126.28%.
What is the RSI of Acutaas Chemicals Ltd.?
The 14-day Relative Strength Index (RSI) of Acutaas Chemicals Ltd. is 46.51, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.
Stock Analysis
Fundamental analysis overview of Acutaas Chemicals Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Strong price momentum
Price Momentum score of 87.3 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term
What is Price Momentum score?
87.3 / 100
Analysts have been raising forward EPS estimates
Analyst EPS estimate (consensus) for forward EPS has increased by 6.44% in the last 3 months, indicating earnings momentum
What is Earnings upgrade (3M)?
High and improving ROE
The company reported strong ROE of 24.05% for 12-month ended 30 Jun 2026 and ROE improved by 805 bps from 1 year ago
What is ROE (FY)?
High and improving operating margin
The company reported strong operating margin of 33.18% for 12-month ended 30 Jun 2026 and operating margin improved by 1150 bps from 1 year ago
What is Operating profit margin?
Strong revenue growth and above median growth of industry
The company delivered strong revenue growth of 40.9% for 12-month ended 30 Jun 2026 and the growth was 30.31 percentage points higher than median growth of industry
What is Sales growth (1Y)?
Median: 10.59
Value 40.9
-99.6111701.8
Strong EPS growth and above median growth of industry
The company delivered strong EPS growth of 102.29% for 12-month ended 30 Jun 2026 and the growth was 95.09 percentage points higher than median growth of industry
What is EPS growth (1Y)?
Low Debt to Equity, not much change from last year
The company has low Debt to Equity of 0.02 as on 30 Jun 2026 and Debt to Equity increased marginally by 0.01 in the last 1 year
What is Debt to Equity?
Consistently pays dividend
The company has not missed dividend payments once in the last 4 financial years
What is Dividend streak?
Company is net cash
The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet
What is Net Debt ?
Negative
Expensive and at a premium to industry median P/E
PE TTM of 67.33 indicates that the stock is expensive on a standalone basis and is at a 111.86% premium to industry median P/E
What is P/E Ratio?
Median: 31.78
Value 67.33
-0.96721.13
Low dividend yield
The company has a low dividend yield of 0.08%
What is Dividend yield?
Neutral
Company's earnings are of moderate quality
Earnings quality score of 54.5 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
54.5 / 100
Stock in ASM list
The stock has been places in Additional Surveillance Measure (ASM) list (LTASM - I (13)).
Company Profile
Overview of Acutaas Chemicals Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Acutaas Chemicals Limited, formerly Ami Organics Limited, is an India-based company, which is engaged in the manufacturing of pharma intermediates and specialty chemicals. It is focused on the development and manufacturing of advanced pharmaceutical intermediates (Pharma Intermediates), New Chemical Entities (NCE) and other specialty chemicals for pharmaceuticals, agrochemicals, dyes, polymers, personal care, animal food, and other industries. It manufactures pharma intermediates for certain active pharmaceutical ingredients (APIs), including dolutegravir, trazodone, entacapone, nintedanib, and rivaroxaban. The pharma intermediates cater to several therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant. It has developed and commercialized over 610 plus products, including specialty chemicals, Pharma Intermediates for APIs across 23 key therapeutic areas.
Acutaas Chemicals Limited, formerly Ami Organics Limited, is an India-based company, which is engaged in the manufacturing of pharma intermediates and specialty chemicals. It is focused on the development and manufacturing of advanced pharmaceutical intermediates (Pharma Intermediates), New Chemical...
Key personnel
Mr. Bhavin N. Shah
Chief Financial Officer
Mr. Chetansinh Parmar
Chief Information Security Officer
Mrs. Ekta Kumari Srivastava
Company Secretary and Compliance Officer
Mr. Nareshkumar Ramjibhai PatelD
Executive Chairman of the Board and Managing Director